Core Viewpoint - A class action lawsuit has been filed against 3D Systems Corporation, alleging that the company made misleading statements regarding its financial health and the impact of customer spending on its business [3][4]. Financial Performance - For Q4 2024, 3D Systems reported a non-GAAP loss of $0.19 per share, missing consensus estimates by $0.08 [6]. - Q4 revenue was $111 million, representing a 3.4% year-over-year decline and falling short of expectations by $4.17 million [6]. - Full-year revenue for 2024 was $440.1 million, a 10% decline year-over-year attributed to lower hardware sales and macroeconomic challenges [6]. - The company experienced a $9 million revenue reduction in Q4 related to revised accounting estimates for its Regenerative Medicine Program [6]. Recent Developments - On March 26, 2025, 3D Systems disclosed its Q4 and full-year 2024 financial results, leading to a nearly 21% decline in its stock price [4]. - On May 12, 2025, the company announced its Q1 2025 results, revealing a revenue of $94.5 million, an 8% year-over-year decline, and a net loss of $37 million, more than double the loss from Q1 2024 [6]. - The company withdrew its full-year 2025 guidance, citing ongoing softness in customer capital spending and broader macroeconomic uncertainty [4][6]. Legal Context - The class action lawsuit represents investors who purchased securities between August 13, 2024, and May 12, 2025, with a deadline of August 12, 2025, to file a lead plaintiff motion [1]. - Allegations include that 3D Systems understated the impact of weakened customer spending and overstated its ability to navigate challenging market conditions [3].
3D Systems Corporation Investors: Please contact the Portnoy Law Firm to recover your losses; August 12, 2025 Deadline to file Lead Plaintiff Motion